Thailand–Taiwan Join Hands with Japan to Advance Precision Medicine Through Cellular Technology

“CytoAurora Thailand–Taiwan” strengthens global expansion, signing an MOU with Chiba University Hospital to elevate precision medicine with advanced cellular screening innovation

[Chiba City, Japan – February 5, 2026] CytoAurora (Thailand) Co., Ltd. and CytoAurora (Taiwan) Co., Ltd. have announced a major milestone in expanding their international collaboration. Dr. Kich Aungvitulsatit, President of CytoAurora (Thailand) Co., Ltd., and Dr. Huang Chung-Erh, Managing Director of CytoAurora (Taiwan) Co., Ltd., traveled to Japan to sign a Memorandum of Understanding (MOU) with Chiba University Hospital, one of Japan’s leading medical institutions.